Brevan Howard Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.21M | Buy |
79,372
+73,154
| +1,176% | +$5.72M | 0.04% | 244 |
|
|
2025
Q1 | $451K | Sell |
6,218
-5,649
| -48% | -$409K | ﹤0.01% | 706 |
|
|
2024
Q4 | $879K | Buy |
11,867
+8,712
| +276% | +$645K | 0.01% | 431 |
|
|
2024
Q3 | $208K | Sell |
3,155
-27,034
| -90% | -$1.78M | ﹤0.01% | 925 |
|
|
2024
Q2 | $2.79M | Buy |
30,189
+19,870
| +193% | +$1.84M | 0.02% | 114 |
|
|
2024
Q1 | $986K | Buy |
10,319
+4,469
| +76% | +$427K | 0.01% | 229 |
|
|
2023
Q4 | $446K | Buy |
+5,850
| New | +$446K | 0.01% | 488 |
|